Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

[Family relations and behavioral-emotional problems in adolescents - an analysis with the adolescent version of the Family Relations Test for Children and Adolescents].

Döpfner M, Schürmann S, Bruß M, Müller S, Rademacher C, Breuer D.

Z Kinder Jugendpsychiatr Psychother. 2018 Jul;46(4):316-324. doi: 10.1024/1422-4917/a000593. Epub 2018 Jun 13. German.

PMID:
29897013
2.

Daily Moderate Exercise Is Beneficial and Social Stress Is Detrimental to Disease Pathology in Murine Lupus Nephritis.

Aqel SI, Hampton JM, Bruss M, Jones KT, Valiente GR, Wu LC, Young MC, Willis WL, Ardoin S, Agarwal S, Bolon B, Powell N, Sheridan J, Schlesinger N, Jarjour WN, Young NA.

Front Physiol. 2017 Apr 26;8:236. doi: 10.3389/fphys.2017.00236. eCollection 2017.

3.

Estrogen-regulated STAT1 activation promotes TLR8 expression to facilitate signaling via microRNA-21 in systemic lupus erythematosus.

Young NA, Valiente GR, Hampton JM, Wu LC, Burd CJ, Willis WL, Bruss M, Steigelman H, Gotsatsenko M, Amici SA, Severin M, Claverie LM, Guerau-de-Arellano M, Lovett-Racke A, Ardoin S, Jarjour WN.

Clin Immunol. 2017 Mar;176:12-22. doi: 10.1016/j.clim.2016.12.005. Epub 2016 Dec 27.

4.

Reduced in vivo hepatic proteome replacement rates but not cell proliferation rates predict maximum lifespan extension in mice.

Thompson AC, Bruss MD, Price JC, Khambatta CF, Holmes WE, Colangelo M, Dalidd M, Roberts LS, Astle CM, Harrison DE, Hellerstein MK.

Aging Cell. 2016 Feb;15(1):118-27. doi: 10.1111/acel.12414. Epub 2015 Nov 6.

5.

A chimeric human-mouse model of Sjögren's syndrome.

Young NA, Wu LC, Bruss M, Kaffenberger BH, Hampton J, Bolon B, Jarjour WN.

Clin Immunol. 2015 Jan;156(1):1-8. doi: 10.1016/j.clim.2014.10.004. Epub 2014 Oct 24.

6.

Fibroblast growth factor 21 is not required for the reductions in circulating insulin-like growth factor-1 or global cell proliferation rates in response to moderate calorie restriction in adult mice.

Thompson AC, Bruss MD, Nag N, Kharitonenkov A, Adams AC, Hellerstein MK.

PLoS One. 2014 Nov 4;9(11):e111418. doi: 10.1371/journal.pone.0111418. eCollection 2014.

7.

Oral administration of nano-emulsion curcumin in mice suppresses inflammatory-induced NFκB signaling and macrophage migration.

Young NA, Bruss MS, Gardner M, Willis WL, Mo X, Valiente GR, Cao Y, Liu Z, Jarjour WN, Wu LC.

PLoS One. 2014 Nov 4;9(11):e111559. doi: 10.1371/journal.pone.0111559. eCollection 2014.

8.

A Method Utilizing Ultra-High Performance Liquid Chromatography with Ultraviolet and Mass Spectrometric Detection for the Analysis of Material Extracts Produced during a Controlled Extraction Study.

Zdravkovic SA, Bruss MD, Piccoli RF, Wood DM.

PDA J Pharm Sci Technol. 2014 Sep-Oct;68(5):504-26. doi: 10.5731/pdajpst.2014.00992.

PMID:
25336421
9.

Integrative analysis of a cross-loci regulation network identifies App as a gene regulating insulin secretion from pancreatic islets.

Tu Z, Keller MP, Zhang C, Rabaglia ME, Greenawalt DM, Yang X, Wang IM, Dai H, Bruss MD, Lum PY, Zhou YP, Kemp DM, Kendziorski C, Yandell BS, Attie AD, Schadt EE, Zhu J.

PLoS Genet. 2012;8(12):e1003107. doi: 10.1371/journal.pgen.1003107. Epub 2012 Dec 6.

10.

Calorie restriction does not increase short-term or long-term protein synthesis.

Miller BF, Robinson MM, Reuland DJ, Drake JC, Peelor FF 3rd, Bruss MD, Hellerstein MK, Hamilton KL.

J Gerontol A Biol Sci Med Sci. 2013 May;68(5):530-8. doi: 10.1093/gerona/gls219. Epub 2012 Oct 26.

11.

The effect of long term calorie restriction on in vivo hepatic proteostatis: a novel combination of dynamic and quantitative proteomics.

Price JC, Khambatta CF, Li KW, Bruss MD, Shankaran M, Dalidd M, Floreani NA, Roberts LS, Turner SM, Holmes WE, Hellerstein MK.

Mol Cell Proteomics. 2012 Dec;11(12):1801-14. doi: 10.1074/mcp.M112.021204. Epub 2012 Sep 13.

12.

A comprehensive assessment of mitochondrial protein synthesis and cellular proliferation with age and caloric restriction.

Miller BF, Robinson MM, Bruss MD, Hellerstein M, Hamilton KL.

Aging Cell. 2012 Feb;11(1):150-61. doi: 10.1111/j.1474-9726.2011.00769.x. Epub 2011 Dec 28.

13.

Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype.

Ahmadian M, Abbott MJ, Tang T, Hudak CS, Kim Y, Bruss M, Hellerstein MK, Lee HY, Samuel VT, Shulman GI, Wang Y, Duncan RE, Kang C, Sul HS.

Cell Metab. 2011 Jun 8;13(6):739-48. doi: 10.1016/j.cmet.2011.05.002.

14.

Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization.

Walstab J, Steinhagen F, Brüss M, Göthert M, Bönisch H.

Pharmacol Rep. 2011;63(1):45-53.

15.

The effects of physiological adaptations to calorie restriction on global cell proliferation rates.

Bruss MD, Thompson AC, Aggarwal I, Khambatta CF, Hellerstein MK.

Am J Physiol Endocrinol Metab. 2011 Apr;300(4):E735-45. doi: 10.1152/ajpendo.00661.2010. Epub 2011 Feb 1.

16.

Serotonin receptor diversity in the human colon: Expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E.

Kapeller J, Möller D, Lasitschka F, Autschbach F, Hovius R, Rappold G, Brüss M, Gershon MD, Niesler B.

J Comp Neurol. 2011 Feb 15;519(3):420-32. doi: 10.1002/cne.22525.

17.

Phosphodiesterase 4B is essential for T(H)2-cell function and development of airway hyperresponsiveness in allergic asthma.

Jin SL, Goya S, Nakae S, Wang D, Bruss M, Hou C, Umetsu D, Conti M.

J Allergy Clin Immunol. 2010 Dec;126(6):1252-9.e12. doi: 10.1016/j.jaci.2010.08.014. Epub 2010 Nov 3.

18.

RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits.

Walstab J, Hammer C, Lasitschka F, Möller D, Connolly CN, Rappold G, Brüss M, Bönisch H, Niesler B.

J Biol Chem. 2010 Aug 27;285(35):26956-65. doi: 10.1074/jbc.M110.122838. Epub 2010 Jun 3.

19.

Thyroidal radioactive iodide uptake in the lactating rhesus monkey.

Ozpinar A, Bruss M, Shelton D, Gillespie J.

Lab Anim. 2010 Apr;44(2):155-8. doi: 10.1258/la.2009.009014. Epub 2009 Dec 3.

PMID:
19959568
20.

Characterization of the naturally occurring Arg344His variant of the human 5-HT 3A receptor.

Combrink S, Kostanian A, Walstab J, Barann M, Brüss M, Göthert M, Bönisch H.

Pharmacol Rep. 2009 Sep-Oct;61(5):785-97.

21.

Calorie restriction increases fatty acid synthesis and whole body fat oxidation rates.

Bruss MD, Khambatta CF, Ruby MA, Aggarwal I, Hellerstein MK.

Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E108-16. doi: 10.1152/ajpendo.00524.2009. Epub 2009 Nov 3.

22.

Effects of intravenous administration of pirfenidone on horses with experimentally induced endotoxemia.

Poulin Braim AE, MacDonald MH, Bruss ML, Grattendick KJ, Giri SN, Margolin SB.

Am J Vet Res. 2009 Aug;70(8):1031-42. doi: 10.2460/ajvr.70.8.1031.

PMID:
19645586
23.

Childhood obesity prevention: an intervention targeting primary caregivers of school children.

Bruss MB, Michael TJ, Morris JR, Applegate B, Dannison L, Quitugua JA, Palacios RT, Klein DJ.

Obesity (Silver Spring). 2010 Jan;18(1):99-107. doi: 10.1038/oby.2009.111. Epub 2009 May 7.

24.

Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes.

Haenisch B, Linsel K, Brüss M, Gilsbach R, Propping P, Nöthen MM, Rietschel M, Fimmers R, Maier W, Zobel A, Höfels S, Guttenthaler V, Göthert M, Bönisch H.

Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):1013-6. doi: 10.1002/ajmg.b.30912.

PMID:
19105200
25.

Alternate-day fasting reduces global cell proliferation rates independently of dietary fat content in mice.

Varady KA, Roohk DJ, Bruss M, Hellerstein MK.

Nutrition. 2009 Apr;25(4):486-91. doi: 10.1016/j.nut.2008.10.017. Epub 2008 Dec 11.

PMID:
19084375
26.

Pharmacokinetics and clinical effects of pirfenidone administered intravenously in horses.

Braim AE, Macdonald MH, Bruss ML, Stanley SD, Giri JK, Giri SN.

Am J Vet Res. 2008 Jul;69(7):952-60. doi: 10.2460/ajvr.69.7.952.

PMID:
18593250
27.

Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts.

Bruss MD, Richter W, Horner K, Jin SL, Conti M.

J Biol Chem. 2008 Aug 15;283(33):22430-42. doi: 10.1074/jbc.M803306200. Epub 2008 May 28.

28.

Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4.

Richter W, Day P, Agrawal R, Bruss MD, Granier S, Wang YL, Rasmussen SG, Horner K, Wang P, Lei T, Patterson AJ, Kobilka B, Conti M.

EMBO J. 2008 Jan 23;27(2):384-93. doi: 10.1038/sj.emboj.7601968. Epub 2008 Jan 10.

29.

Pharmacokinetics and metabolism of intravenous pirfenidone in sheep.

Bruss ML, Stanley SD, Margolin SB, Giri SN.

Biopharm Drug Dispos. 2008 Mar;29(2):119-26. doi: 10.1002/bdd.595.

PMID:
18176939
30.

Molecular cloning and functional expression of the murine noradrenaline transporter.

Muck A, Gilsbach R, Löbbe-Werner S, Brüss M, Bönisch H.

Naunyn Schmiedebergs Arch Pharmacol. 2007 Oct;376(1-2):65-71. Epub 2007 Sep 19.

PMID:
17882401
31.

Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder.

Molderings GJ, Kolck UW, Scheurlen C, Brüss M, Homann J, Von Kügelgen I.

Scand J Gastroenterol. 2007 Sep;42(9):1045-53.

PMID:
17710669
32.

Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.

Walstab J, Combrink S, Brüss M, Göthert M, Niesler B, Bönisch H.

Anal Biochem. 2007 Sep 15;368(2):185-92. Epub 2007 Jun 8.

PMID:
17617370
33.

S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I(1) receptor ligands.

Molderings GJ, Bönisch H, Brüss M, Wolf C, von Kügelgen I, Göthert M.

Neurochem Int. 2007 Dec;51(8):476-85. Epub 2007 May 7.

PMID:
17559976
34.

Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E.

Niesler B, Walstab J, Combrink S, Möller D, Kapeller J, Rietdorf J, Bönisch H, Göthert M, Rappold G, Brüss M.

Mol Pharmacol. 2007 Jul;72(1):8-17. Epub 2007 Mar 28.

PMID:
17392525
35.

Ethnicity and diet of children: development of culturally sensitive measures.

Bruss MB, Applegate B, Quitugua J, Palacios RT, Morris JR.

Health Educ Behav. 2007 Oct;34(5):735-47. Epub 2007 Feb 7.

PMID:
17287492
36.

Molecular basis for the antiproliferative effect of agmatine in tumor cells of colonic, hepatic, and neuronal origin.

Wolf C, Brüss M, Hänisch B, Göthert M, von Kügelgen I, Molderings GJ.

Mol Pharmacol. 2007 Jan;71(1):276-83. Epub 2006 Oct 17.

PMID:
17047095
37.

[Systemic mast cell disease with gastrointestinal symptoms--a diagnostic questionnaire].

Molderings GJ, Kolck U, Scheurlen C, Brüss M, Frieling T, Raithel M, Homann J.

Dtsch Med Wochenschr. 2006 Sep 22;131(38):2095-100. Review. German.

PMID:
16981082
38.
39.

The norepinephrine transporter in physiology and disease.

Bönisch H, Brüss M.

Handb Exp Pharmacol. 2006;(175):485-524. Review.

PMID:
16722247
41.

Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.

Amphoux A, Vialou V, Drescher E, Brüss M, Mannoury La Cour C, Rochat C, Millan MJ, Giros B, Bönisch H, Gautron S.

Neuropharmacology. 2006 Jun;50(8):941-52. Epub 2006 Mar 31.

PMID:
16581093
42.

Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data.

Gilsbach R, Kouta M, Bönisch H, Brüss M.

Biotechniques. 2006 Feb;40(2):173-7.

43.

Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis.

Barann M, Urban B, Stamer U, Dorner Z, Bönisch H, Brüss M.

Eur J Pharmacol. 2006 Feb 15;531(1-3):54-8. Epub 2006 Jan 19.

PMID:
16427041
44.

Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors.

Gilsbach R, Faron-Górecka A, Rogóz Z, Brüss M, Caron MG, Dziedzicka-Wasylewska M, Bönisch H.

J Neurochem. 2006 Feb;96(4):1111-20. Epub 2006 Jan 17.

45.

Food, culture, and family: exploring the coordinated management of meaning regarding childhood obesity.

Bruss MB, Morris JR, Dannison LL, Orbe MP, Quitugua JA, Palacios RT.

Health Commun. 2005;18(2):155-75.

PMID:
16083409
46.

Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriers.

Walkembach J, Brüss M, Urban BW, Barann M.

Br J Pharmacol. 2005 Oct;146(4):543-52. Erratum in: Br J Pharmacol. 2005 Dec;146(8):1156.

47.

Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.

Brüss M, Kiel S, Bönisch H, Kostanian A, Göthert M.

Neurochem Int. 2005 Aug;47(3):196-203.

PMID:
15896881
48.

The naturally occurring Arg219Leu variant of the human 5-HT1A receptor: impairment of signal transduction.

Brüss M, Kostanian A, Bönisch H, Göthert M.

Pharmacogenet Genomics. 2005 Apr;15(4):257-64.

PMID:
15864118
49.

Systematic investigation of genetic variability in 111 human genes-implications for studying variable drug response.

Freudenberg-Hua Y, Freudenberg J, Winantea J, Kluck N, Cichon S, Brüss M, Propping P, Nöthen MM.

Pharmacogenomics J. 2005;5(3):183-92.

PMID:
15809674
50.

Supplemental Content

Support Center